SUBSCRIBE
SUBSCRIBE
News   Business

Alexion Pharmaceuticals Inc. Q2 Profit Beats Street, Raises FY 2009 Outlook

July 23, 2009 | 
1 min read
Reuters - Alexion Pharmaceuticals Inc (ALXN.O) posted higher quarterly earnings, helped by a 55 percent jump in revenue from its genetic-disorder drug Soliris, and raised its 2009 full-year outlook.
Earnings
Alexion
MORE ON THIS TOPIC
Collaboration of personnel with artificial intelligence, Setting goals to improve company growth with the support of AI, New innovative concept, Businessman runs up on robot hand pointing upwards.
Artificial intelligence
AstraZeneca bulks up MASH, cardio work in up to $1.5B AI partnership with insitro
October 15, 2026
 · 
1 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
GSK laying off 1.2K+ in Belgium
October 15, 2026
 · 
102 min read
 · 
BioSpace Editorial Staff
A businessmans hand handing a key to another hand, illustration of offering and providing solutions for business challenges
Deals
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
October 15, 2026
 · 
4 min read
 · 
Annalee Armstrong
Business analytics, statistical data collection, profit sharing, information management concept. Hand with fork holding piece of pie diagram. Minimalistic art collage
Licensing
Gilead snags equity stake in Vir with up to $1.87B deal for three T cell engagers
October 14, 2026
 · 
1 min read
 · 
Annalee Armstrong